DexCom
DXCM
DXCM
720 hedge funds and large institutions have $37.4B invested in DexCom in 2020 Q2 according to their latest regulatory filings, with 192 funds opening new positions, 249 increasing their positions, 223 reducing their positions, and 60 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
12% more repeat investments, than reductions
Existing positions increased: 249 | Existing positions reduced: 223
7% more call options, than puts
Call options by funds: $463M | Put options by funds: $434M
0% more ownership
Funds ownership: 400.04% → 400.04% (+0%)
Holders
720
Holding in Top 10
22
Calls
$463M
Puts
$434M
Top Buyers
| 1 | +$745M | |
| 2 | +$621M | |
| 3 | +$544M | |
| 4 |
BlackRock
New York
|
+$465M |
| 5 |
Goldman Sachs
New York
|
+$235M |
Top Sellers
| 1 | -$540M | |
| 2 | -$283M | |
| 3 | -$240M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$235M |
| 5 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$182M |